517 related articles for article (PubMed ID: 34562466)
1. Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.
Beyer DK; Forero A
J Mol Biol; 2022 Mar; 434(6):167265. PubMed ID: 34562466
[TBL] [Abstract][Full Text] [Related]
2. Type I and III interferon responses in SARS-CoV-2 infection.
Kim YM; Shin EC
Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
4. Interferon antagonists encoded by SARS-CoV-2 at a glance.
Lee JH; Koepke L; Kirchhoff F; Sparrer KMJ
Med Microbiol Immunol; 2023 Apr; 212(2):125-131. PubMed ID: 35366686
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
Oh SJ; Shin OS
J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
[TBL] [Abstract][Full Text] [Related]
7. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.
Kehrer T; García-Sastre A; Miorin L
J Interferon Cytokine Res; 2021 Jun; 41(6):205-219. PubMed ID: 34161170
[TBL] [Abstract][Full Text] [Related]
8. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19.
Lowery SA; Sariol A; Perlman S
Cell Host Microbe; 2021 Jul; 29(7):1052-1062. PubMed ID: 34022154
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
[TBL] [Abstract][Full Text] [Related]
10. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
Quarleri J; Delpino MV
Cytokine Growth Factor Rev; 2021 Apr; 58():55-65. PubMed ID: 33608189
[TBL] [Abstract][Full Text] [Related]
11. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
[TBL] [Abstract][Full Text] [Related]
12. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.
Hayn M; Hirschenberger M; Koepke L; Nchioua R; Straub JH; Klute S; Hunszinger V; Zech F; Prelli Bozzo C; Aftab W; Christensen MH; Conzelmann C; Müller JA; Srinivasachar Badarinarayan S; Stürzel CM; Forne I; Stenger S; Conzelmann KK; Münch J; Schmidt FI; Sauter D; Imhof A; Kirchhoff F; Sparrer KMJ
Cell Rep; 2021 May; 35(7):109126. PubMed ID: 33974846
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
14. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
15. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
16. Innate immune sensing of coronavirus and viral evasion strategies.
Kasuga Y; Zhu B; Jang KJ; Yoo JS
Exp Mol Med; 2021 May; 53(5):723-736. PubMed ID: 33953325
[TBL] [Abstract][Full Text] [Related]
17. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
[TBL] [Abstract][Full Text] [Related]
18. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.
Zhang S; Wang L; Cheng G
Mol Ther; 2022 May; 30(5):1869-1884. PubMed ID: 35176485
[TBL] [Abstract][Full Text] [Related]
19. Roles of Type I and III Interferons in COVID-19.
Choi H; Shin EC
Yonsei Med J; 2021 May; 62(5):381-390. PubMed ID: 33908208
[TBL] [Abstract][Full Text] [Related]
20. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.
Zhang J; Zhao C; Zhao W
Front Immunol; 2021; 12():633769. PubMed ID: 33912161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
